Companies Directory

Celleron Therapeutics is a biopharmaceutical company focusing on new and innovative cancer treatments. Celleron’s Vision is to build a global pipeline of clinical products which are safe and effective in unmet indications, supported by a precision medicine platform.

Cell therapies are revolutionizing the treatment of disease and are poised to transform health outcomes. Advances in biology and technology have enabled the development of innovation in a more distributed way than ever before: there is a wave of novel therapeutics in academic centers and biotechs around the world looking for partners to advance their inventions. That’s where we come in. Our approach is to bring clinical stage therapies through late stage development and commercialization by partnering with innovators at academic medical centers and small biotechs around the world. Headquartered in San Francisco, CA, the company is backed by seed investment from National Resilience, Inc., Hibiscus BioVentures, and Jumpstart Nova, as well as several high-net-worth individuals.

CellFree Sciences (CFS) provides comprehensive solutions for protein production and analysis using the ENDEXT Technology Platform originally developed by Prof. Yaeta Endo at Ehime University in Japan. Based on our different WEPRO wheat germ protein expression extracts, we are serving the research community with protein synthesis services, reagents, and the fully automated Protemist robotic protein production systems. Our protein expression systems are proven to work for a wide range of different proteins providing superior protein solubility and yields under controlled conditions starting directly from cDNA templates. Many thousands of proteins from microorganisms to mammalians have been successfully produced by our technology, for example for crystallography, NMR, mass spectroscopy, protein engineering, antigen production, and protein-protein interaction screening. CFS is an active partner working closely together with academic research centers and Life Science Companies on joint R&D projects for protein analysis, high-throughput compound screening, and assay development, or using our new human Protein Active Arrays (PAA) for biomarker discovery and autoantibody profiling. With our platform technologies, CFS wants to contribute to the molecular understanding of life by serving the research community, while supporting life science industries on the development of innovative diagnostic and therapeutic products.

UVCDR Cellier des Dauphins is a wine and spirits company based out of France.

UVCDR Cellier des Dauphins is a wine and spirits company based out of France.

- “Exclusive” network sites. More than 450k current available sites. - Plug&Play outdoor infrastructure solution to host wireless equipment. - Ideal deployment model for MNOs and landlords. - Massive and efficient deployment and maintenance of short-range telecom wireless infrastructure.

Cellion Tekstil is a successful business partner that applies fashion of the moment to design and to production according to customers’ preferences. Our company has both a strong design team, a member of WGSN, that follows current trends and an infrastructure with which your designs can be produced with the requested quality and under the optimum conditions. Certified by Sedex, BSCI, the production process in Cellion includes all stages from raw fiber to finished product. It has also been APPROVED in inspections performed on behalf of customers including Bureau Veritas, Jennyfer, SGS, M&S, Kiabi. All Processes from Model to Fabric, from Cut to Sewing, from Sewing to Quality Control and Packaging and from Packaging to Product Warehouse that will effect our Production and Service Quality are under our control. With our international experience and background, we regularly present about 150 new collections and 800.000 pieces every month to our customers. Say Hello to Cellion and let’s talk about what we can do together. For further information please contact - info@cellion.com.tr

CELLIPSE is a drug discovery company based in Grenoble, France dedicated to bringing innovative therapies to cancer patients and healthcare professionals. We are building a pipeline of small molecules targeting the cytoskeleton (i.e. microtubules and actin filaments) based on our « cell to drug discovery » approach.